Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Storey

Neurological Surgery Hermitage, TN Medical Doctor

NPI 1811289135 CMS profile 4223761

5653 Frist Blvd Ste 738, Hermitage, TN 37076

Open in the dashboard

General payments

$58,668

314 records reported · program years 2019–2025

Research payments

$30,305

Paid to them · 12 records reported · program years 2019–2025

Ownership & investment interest

$1,073,817

3 holdings reported · through program year 2025

Through program year 2025, Christopher Storey of Hermitage, TN is reported in the CMS Open Payments database as having received $58,668 across 314 general payments and $30,305 in research payments paid to them. They also declared ownership or investment interests valued at $1,073,817 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,955 26
2025 Research $15,080 5
2024 General $2,925 50
2024 Research $9,135 4
2023 General $26,500 54
2023 Research $6,090 3
2022 General $2,794 48
2021 General $12,842 62
2020 General $6,850 32
2019 General $3,803 42
2025 Ownership $357,939 1
2024 Ownership $357,939 1
2023 Ownership $357,939 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Storey
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Christopher Storey were reported at $2,955. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Christopher Storey Neurological Surgery median Middle half National median
2019 $3,803 $582 $138–$3,006 $163
2020 $6,850 $294 $76–$2,174 $114
2021 $12,842 $387 $105–$2,432 $132
2022 $2,794 $542 $139–$2,989 $149
2023 $26,500 $534 $145–$2,697 $160
2024 $2,925 $574 $155–$3,046 $164
2025 $2,955 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $29,938 32 payments
  2. MicroVention, Inc. $9,543 16 payments
  3. Medtronic USA, Inc. $6,632 19 payments
  4. iSchemaView, Inc. $3,100 3 payments
  5. Abbott Laboratories $2,319 111 payments
  6. Globus Medical, Inc. $1,665 17 payments
  7. Medical Device Business Services, Inc. $1,160 1 payment
  8. DePuy Synthes Sales Inc. $669 19 payments
  9. Nevro Corp. $536 15 payments
  10. Boston Scientific Corporation $454 15 payments
  11. Other $2,653 66 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $31,215 8 payments
  2. Consulting Fee $11,390 7 payments
  3. Food and Beverage $8,687 271 payments
  4. Travel and Lodging $7,377 28 payments
Products named General payments · program years 2019–2025
  1. RIST $13,920 1 payment
  2. WEB ANEURYSM EMBOLIZATION SYSTEM $7,227 7 payments
  3. Rist-5F $7,192 3 payments
  4. Axium $2,900 1 payment
  5. SOLITAIRE X $2,188 12 payments
  6. WEB $1,566 8 payments
  7. PROCLAIM $1,264 44 payments
  8. EMBOGUARD $1,180 2 payments
  9. Pipeline $1,052 8 payments
  10. O-ARM-ST $825 7 payments
  11. Other $9,433 234 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $30,305 12 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

38

Median for Neurosurgery: 83

Drug cost

$290

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 38 $290

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 79 billing codes

Paid by Medicare

$213,092

Medicare's payments for the services billed

Medicare patients

285

Average age 75

Services billed

993

155 women, 130 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Diabetes 42%
Ischemic heart disease 42%
Depression 40%
Chronic kidney disease 33%
Atrial fibrillation 27%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

326 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record